Developed in the 1970s, transrectal ultrasound of the prostate applied to biopsy of that organ started to be used more widely in the 1980s (1, 2). In that decade, the use of this technology among renowned teams allowed great knowledge to be acquired about prostate anatomy, the procedure and complications (3, 4). Much has been changed since then, devices have developed substantially, new imaging methods have been added, protocols and guidelines have been outlined for the proper use of this diagnostic tool. So, after more than 30 years of publications, the most skeptical of urologists would say that this science is exhausted, and no other paper could emerge on this topic. With great satisfaction, the International Brazilian Journal of Urology once again brings to our dear readers an assessment of prostate biopsy guided by ultrasound from a different perspective. In previous editions, new data about complications of the procedure (5) and evaluation of the pain pattern in different methods of sample acquisition (6) were presented. In this issue we bring you an article that discusses the mood disorders associated with biopsy and positive results. The wide access and use of screening methods, made part of our actions somewhat mythical. The lack of real understanding about PSA and all the taboos inherent to digital rectal examination, together are enough to create a fog of doubt and fear among men in the age group for screening. In other areas of oncology, where screening methods are possible, patients also face similar challenges before diagnosis; and once it is done, a storm of dubious thoughts sets in their minds and souls. Among women, confirmation of a breast cancer or a cervical and its treatment may impact on self-image and sexual concerns which may lead to mood disorders and worsening quality of life (7-10). Likewise, a positive diagnosis through colonoscopic screening for malignancies can bring countless questions to the patient who, without assertive information or even without adequate support, can develop anxiety or depression (11). In the present study Sefik et al. demonstrated that, before biopsy, levels of anxiety and depression measured were correlated with serum levels of PSA. Demonstrating one of the negative effects that a "simple blood test" could have on individuals. And they show us more: just after biopsy, those symptoms disappeared; this is related to the good practice adopted in that department, where the patient is well oriented on the technique of the procedure just before it (12). In Rio de Janeiro, Brazil, at the National Cancer Institute-INCa-a branch of the Urology Department, the Prostate Cancer Diagnosis Center-CDCP-welcomes referral patients from all over the state, whose biopsy was requested in primary care by a family and community physician or even by urologists serving in public settings. Understanding the burden of expectations related to that referral, our Center proposes a multi-professional approach to the patient and his family.